CY1124728T1 - Παραγωγα βενζοξαβορολης για τη θεραπεια βακτηριακων λοιμωξεων - Google Patents

Παραγωγα βενζοξαβορολης για τη θεραπεια βακτηριακων λοιμωξεων

Info

Publication number
CY1124728T1
CY1124728T1 CY20211100990T CY211100990T CY1124728T1 CY 1124728 T1 CY1124728 T1 CY 1124728T1 CY 20211100990 T CY20211100990 T CY 20211100990T CY 211100990 T CY211100990 T CY 211100990T CY 1124728 T1 CY1124728 T1 CY 1124728T1
Authority
CY
Cyprus
Prior art keywords
unsubstituted
treatment
bacterial infections
substituted
benzoxaborole
Prior art date
Application number
CY20211100990T
Other languages
Greek (el)
English (en)
Inventor
Vincent S. Hernandez
Charles Ding
Jacob J. Plattner
Michael Richard Kevin Alley
Eric Easom
Xianfeng Li
Ding Zhou
Fernando Rock
Suoming Zhang
Original Assignee
Anacor Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44653589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1124728(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Anacor Pharmaceuticals, Inc. filed Critical Anacor Pharmaceuticals, Inc.
Publication of CY1124728T1 publication Critical patent/CY1124728T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CY20211100990T 2010-09-07 2021-11-16 Παραγωγα βενζοξαβορολης για τη θεραπεια βακτηριακων λοιμωξεων CY1124728T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38059610P 2010-09-07 2010-09-07
EP11758050.6A EP2613788B1 (en) 2010-09-07 2011-09-07 Benzoxaborole derivatives for treating bacterial infections
PCT/US2011/050728 WO2012033858A2 (en) 2010-09-07 2011-09-07 Boron-containing small molecules

Publications (1)

Publication Number Publication Date
CY1124728T1 true CY1124728T1 (el) 2022-07-22

Family

ID=44653589

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20211100990T CY1124728T1 (el) 2010-09-07 2021-11-16 Παραγωγα βενζοξαβορολης για τη θεραπεια βακτηριακων λοιμωξεων

Country Status (25)

Country Link
US (4) US8703742B2 (enExample)
EP (2) EP3251678B1 (enExample)
JP (4) JP5952280B2 (enExample)
KR (2) KR101949423B1 (enExample)
CN (2) CN103140228A (enExample)
AU (1) AU2011299243C1 (enExample)
BR (1) BR112013005426B1 (enExample)
CA (1) CA2810021C (enExample)
CY (1) CY1124728T1 (enExample)
DK (2) DK3251678T3 (enExample)
EA (2) EA033311B1 (enExample)
ES (2) ES2635333T3 (enExample)
HR (1) HRP20211762T1 (enExample)
HU (1) HUE059033T2 (enExample)
IL (2) IL225000A (enExample)
LT (1) LT3251678T (enExample)
MX (1) MX338209B (enExample)
PL (1) PL3251678T3 (enExample)
PT (1) PT3251678T (enExample)
RS (1) RS62548B1 (enExample)
SG (2) SG187969A1 (enExample)
SI (1) SI3251678T1 (enExample)
SM (1) SMT202100643T1 (enExample)
WO (1) WO2012033858A2 (enExample)
ZA (1) ZA201301598B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0621279B1 (pt) 2005-12-30 2021-07-20 Anacor Pharmaceuticals, Inc Moléculas pequenas contendo boro
AP4039A (en) 2009-08-14 2017-02-28 Daitao Chen Boron-containing small molecules as antiprotozoal agents
WO2011094450A1 (en) 2010-01-27 2011-08-04 Anacor Pharmaceuticals, Inc Boron-containing small molecules
SMT202100643T1 (it) * 2010-09-07 2022-01-10 Anacor Pharmaceuticals Inc Derivati del benzossaborolo per il trattamento delle infezioni batteriche
JP6031122B2 (ja) * 2011-12-22 2016-11-24 ミクウルク ファーマシューティカルズ,インコーポレイテッド 抗微生物療法のための三環式ホウ素化合物
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
EP2950644B1 (en) 2013-01-30 2017-07-19 AgroFresh Inc. Use of benzoxaboroles as volatile antimicrobial agents on meats, plants, or plant parts
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
US9598443B2 (en) 2013-02-01 2017-03-21 Anacor Pharmaceuticals, Inc. Boron containing small molecules as antiprotozoal agents
KR101636431B1 (ko) 2013-07-30 2016-07-05 동아에스티 주식회사 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
WO2015021396A2 (en) * 2013-08-09 2015-02-12 Glaxosmithkline Intellectual Property (No.2) Limited Tricyclic benzoxaborole compounds and uses thereof
EA038093B1 (ru) * 2013-12-20 2021-07-05 Глаксосмитклайн Интеллекчуал Проперти (№2) Лимитед Способ лечения заболевания, вызванного инфекцией комплекса mycobacterium tuberculosis, с использованием (s)-(3-хлор-7,8-дигидро-2h-1,6,9-триокса-9a-борабензо[cd]азулен-2-ил)метанамина или его фармацевтически приемлемой соли
ES2732465T3 (es) 2014-07-01 2019-11-22 Daiichi Sankyo Co Ltd Benzoxaboroles tricíclicos como agentes antibacterianos
MA41495A (fr) 2015-02-12 2017-12-19 Anacor Pharmaceuticals Inc Composés benzoxaborole et leurs utilisations
EP3426029B1 (en) 2016-03-07 2023-08-30 AgroFresh Inc. Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
MA52337A (fr) 2017-03-01 2021-03-03 Anacor Pharmaceuticals Inc Nouveaux analogues d'oxaborole et utilisations de ces derniers
CA3120976A1 (en) 2017-11-30 2019-06-06 Boragen, Inc. Benzoxaborole compounds and formulations thereof
CN108727176B (zh) * 2018-07-26 2021-05-18 荆楚理工学院 一种制备5-卤-2,3-二羟基苯甲醛的方法
MX2021001904A (es) 2018-08-18 2021-05-27 Boragen Inc Formas solidas de benzoxaborol sustituido y composiciones de las mismas.
AR119515A1 (es) * 2019-07-30 2021-12-22 Boragen Inc Proceso de reacción de flujo para la fabricación de agroquímicos que contienen boro
CN110664756B (zh) * 2019-10-09 2020-11-17 吉林大学 一种小儿外伤喷雾剂及其制备方法
US20230340530A1 (en) 2020-08-31 2023-10-26 Pfizer Inc. Methods of Protecting RNA
JP2025520237A (ja) 2022-06-23 2025-07-03 ミクウルク ファーマシューティカルズ, インコーポレイテッド ホウ素化合物を用いて非結核性マイコバクテリア感染症を治療する方法及びその用途、並びに同じ疾患を治療するための医薬組成物
CA3239097A1 (en) * 2022-06-23 2023-12-28 Shanghai Micurx Pharmaceutical Co., Ltd. Prodrugs of boron compounds and their use in treating bacterial infections
CN115572218B (zh) * 2022-08-29 2024-04-16 江阴勒森生物科技有限公司 一种2-溴-3-羟基苯甲醛及其相关化学发光底物中间体的制备方法

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2260336A (en) 1939-10-16 1941-10-28 Dow Chemical Co Method of preparation of organic borates
US3686398A (en) 1970-07-20 1972-08-22 Chevron Res 10,9-boroxarophenanthrene as fungicides
GB1396904A (en) 1972-08-11 1975-06-11 Ici Ltd Method for the control of micro-organisms
US4602011A (en) 1975-10-24 1986-07-22 Chapman Chemical Company Antimicrobial compositions and methods of using same
US4766113A (en) 1975-10-24 1988-08-23 Chapman Chemical Company Antimicrobial compositions and methods of using same
US4716035A (en) 1985-05-24 1987-12-29 The Procter & Gamble Company Oral compositions and methods for treating gingivitis
US5962498A (en) 1986-06-11 1999-10-05 Procyon Pharmaceuticals, Inc. Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity
US4894220A (en) 1987-01-30 1990-01-16 Colgate-Palmolive Company Antibacterial antiplaque oral composition
US4919934A (en) 1989-03-02 1990-04-24 Richardson-Vicks Inc. Cosmetic sticks
US5274792A (en) 1989-08-19 1993-12-28 Fujitsu Limited Information processing apparatus with parallel instruction decoding
SG47101A1 (en) 1992-07-31 1998-03-20 Us Bioscience Crystalline amifostine compositions and methods for the preparation and use of same
US5348948A (en) 1993-05-07 1994-09-20 American Cyanamid Company 2,2-diaryl-1-(oxa and thia)-2a-azonia-2-borataacenaphthene fungicidal
US5348947A (en) 1993-05-07 1994-09-20 American Cyanamid Company Diarylboron ester and thioester fungicidal agents
US5594151A (en) 1994-01-28 1997-01-14 Prolinx, Inc. Phenylboronic acid complexing reagents derived from aminosalicylic acid
GB9411587D0 (en) 1994-06-09 1994-08-03 Zeneca Ltd Compound, composition and use
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
GB9500856D0 (en) 1995-01-17 1995-03-08 Zeneca Ltd Composition and use
GB9604926D0 (en) 1996-03-08 1996-05-08 Sandoz Ltd Organic compounds
WO1997048697A1 (en) 1996-06-19 1997-12-24 Rhone-Poulenc Rorer Limited Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
US5831046A (en) 1996-08-05 1998-11-03 Prolinx, Incorporated Boronic acid-contaning nucleic acid monomers
WO1998012206A1 (en) 1996-09-19 1998-03-26 The Board Of Trustees Of Leland Stanford Jr. University Dna adenine methyltransferases and uses thereof
EP0947498B1 (en) 1996-12-02 2004-09-15 Chisso Corporation Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for preparing the same
US6221640B1 (en) 1997-05-14 2001-04-24 Cubist Pharmaceuticals, Inc. Enterococcal aminoacyl-trna synthetase proteins, nucleic acids and strains comprising same
DE19829947A1 (de) 1998-07-04 2000-01-05 Bayer Ag Elektrolumineszierende Anordnungen mit Bor-Chelaten
US6462036B1 (en) 1998-11-06 2002-10-08 Basf Aktiengesellschaft Tricyclic pyrazole derivatives
TR200102277T2 (tr) 1998-11-06 2002-01-21 Basf Aktiengesellschaft Ag. Üç halkalı (Trisiklik) pirazol türevleri
WO2000044387A1 (fr) 1999-01-29 2000-08-03 Nitto Kasei Co., Ltd. Composes organobores presentant une activite de coccidiostats
CN1370170A (zh) 1999-05-25 2002-09-18 宾夕法尼亚州研究基金会 Dna甲基转移酶抑制剂
US6306628B1 (en) 1999-08-25 2001-10-23 Ambergen, Incorporated Methods for the detection, analysis and isolation of Nascent proteins
CA2383554C (en) 1999-08-25 2008-03-18 Ambergen, Inc. Methods for the detection, analysis and isolation of nascent proteins
AU7995300A (en) 1999-10-05 2001-05-10 Bethesda Pharmaceuticals, Inc. Dithiolane derivatives
CO5271678A1 (es) 2000-01-06 2003-04-30 Marantech Holding Llc Composiciones para facilitar el crecimiento de la piel y metodos y articulos que las emplean
US6521619B2 (en) 2000-06-29 2003-02-18 Icos Corporation Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
CA2415938A1 (en) 2000-07-14 2002-01-24 Zycos Inc. Alpha-msh related compounds and methods of use
JP2004524281A (ja) 2000-11-30 2004-08-12 ザ ペン ステート リサーチ ファウンデイション Dnaメチルトランスフェラーゼ阻害剤
DE10110051C2 (de) 2001-03-02 2003-07-03 Clariant Gmbh Verfahren zur Herstellung von Boron- und Borinsäuren
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
JP2005503425A (ja) 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション 所定の吸入ルートによる薬剤エステルの送出
GB0117645D0 (en) 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
DE10143979A1 (de) 2001-09-07 2003-03-27 Clariant Gmbh Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren
WO2003033002A1 (en) 2001-10-11 2003-04-24 Ono Pharmaceutical Co Intracellular calcium concentration increase inhibitors
CA2473238A1 (en) 2002-01-10 2003-07-24 The Penn State Research Foundation Methods for the preparation of alkyl diaryl borinates and complexed diarylboronic acids
JP2006507352A (ja) 2002-07-09 2006-03-02 ポイント セラピューティクス, インコーポレイテッド イソロイシンのボロプロリン化合物に関する方法および組成物
ES2283867T3 (es) 2002-12-02 2007-11-01 Solvias Ag Hidrogenacion catalitica de dobles enlaces de carbonoheteroatomo.
US7390806B2 (en) 2002-12-18 2008-06-24 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use
CA2509645A1 (en) 2002-12-18 2004-07-08 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use
US20050125852A1 (en) 2003-05-09 2005-06-09 Sugen, Inc. Novel kinases
WO2005013892A2 (en) 2003-06-16 2005-02-17 Anacor Pharmaceuticals, Inc. Hydrolytically-resistant boron-containing therapeutics and methods of use
DK1755661T3 (da) 2004-05-12 2014-06-16 Brigham & Womens Hospital Gelsolin til anvendelse til behandling af infektioner
AR049915A1 (es) 2004-06-14 2006-09-13 Anacor Pharmaceuticals Inc Compuestos con contenido de boro y metodos de uso de los mismos
WO2006062731A1 (en) 2004-11-19 2006-06-15 University Of North Texas Health Science Center At Fort Worth Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye
GB0501944D0 (en) 2005-01-31 2005-03-09 Univ Cambridge Tech Compounds for use in chemical detection and/or quantitation
AU2006214247C1 (en) 2005-02-16 2012-11-08 Anacor Pharmaceuticals, Llc Boron-containing small molecules
WO2006096131A1 (en) 2005-03-08 2006-09-14 Agency For Science, Technology And Research Chiral bisoxazoline catalysts
US20060222671A1 (en) 2005-03-30 2006-10-05 Astion Development A/S Dermatological compositions and salts for the treatment of dermatological diseases
WO2007022437A2 (en) 2005-08-18 2007-02-22 Auspex Pharmaceuticals, Inc. Therapeutic agents for the treatment of cancer and metabolic disorders
BRPI0621279B1 (pt) 2005-12-30 2021-07-20 Anacor Pharmaceuticals, Inc Moléculas pequenas contendo boro
CA2642583C (en) * 2006-02-16 2016-08-23 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents
WO2007131072A2 (en) * 2006-05-02 2007-11-15 Anacor Pharmaceuticals, Inc. Hydrolytically-resistant boron-containing therapeutics and methods of use
US20070286822A1 (en) 2006-06-12 2007-12-13 Anacor Pharmaceuticals Inc. Compounds for the Treatment of Periodontal Disease
WO2007146965A2 (en) 2006-06-12 2007-12-21 Anacor Pharmaceuticals, Inc. Compounds for the treatment of periodontal disease
KR100848491B1 (ko) 2007-01-16 2008-07-28 영진약품공업주식회사 베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
JO3396B1 (ar) * 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
EP2187893A4 (en) 2008-03-06 2012-02-22 Anacor Pharmaceuticals Inc SMALL BORON-CONTAINING MOLECULES AS ANTI-INFLAMMATORY AGENTS
CN102014927A (zh) 2008-03-06 2011-04-13 安纳考尔医药公司 作为抗炎药的含硼的小分子
EP2285384A4 (en) 2008-05-12 2012-04-25 Anacor Pharmaceuticals Inc BORN SMALL MOLECULES
WO2010028005A1 (en) 2008-09-04 2010-03-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2010045505A1 (en) 2008-10-15 2010-04-22 Anacor Pharmaceuticals, Inc Boron-containing small molecules as anti-protozoal agents
US9493489B2 (en) 2008-10-15 2016-11-15 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
AU2009335744A1 (en) 2008-12-17 2010-07-15 Anacor Pharmaceuticals, Inc. Polymorphs of (S)-3-aminomethyl-7-(3-hydroxy-propoxy) -3H-benzo[c][1,2] oxaborol-1-ol
JP2013500974A (ja) 2009-07-28 2013-01-10 アナコール ファーマシューティカルズ,インコーポレイテッド 三置換ホウ素含有分子
SMT202100643T1 (it) 2010-09-07 2022-01-10 Anacor Pharmaceuticals Inc Derivati del benzossaborolo per il trattamento delle infezioni batteriche

Also Published As

Publication number Publication date
KR20140093598A (ko) 2014-07-28
ES2898695T3 (es) 2022-03-08
CN103140228A (zh) 2013-06-05
BR112013005426A2 (pt) 2016-06-07
DK2613788T3 (en) 2017-08-07
EP3251678A1 (en) 2017-12-06
DK3251678T3 (da) 2021-11-22
SG10201507032YA (en) 2015-10-29
RS62548B1 (sr) 2021-12-31
JP5952280B2 (ja) 2016-07-13
JP2019112431A (ja) 2019-07-11
AU2011299243B2 (en) 2015-09-17
SI3251678T1 (sl) 2022-01-31
IL244556B (en) 2020-07-30
SMT202100643T1 (it) 2022-01-10
US20190345173A1 (en) 2019-11-14
EA201390274A1 (ru) 2013-08-30
AU2011299243A1 (en) 2013-03-28
SG187969A1 (en) 2013-04-30
US20170355719A1 (en) 2017-12-14
AU2011299243C1 (en) 2016-06-02
ES2635333T3 (es) 2017-10-03
EA033311B1 (ru) 2019-09-30
CN108610356B (zh) 2021-02-26
MX338209B (es) 2016-04-07
US20120115813A1 (en) 2012-05-10
US11008345B2 (en) 2021-05-18
BR112013005426B1 (pt) 2021-08-24
EP2613788A2 (en) 2013-07-17
JP2013541514A (ja) 2013-11-14
EP2613788B1 (en) 2017-06-21
ES2898695T8 (es) 2022-03-16
CA2810021A1 (en) 2012-03-15
KR20190018549A (ko) 2019-02-22
KR101949423B1 (ko) 2019-02-18
US20140315860A1 (en) 2014-10-23
CN108610356A (zh) 2018-10-02
JP6491294B2 (ja) 2019-03-27
JP2016199558A (ja) 2016-12-01
WO2012033858A2 (en) 2012-03-15
ZA201301598B (en) 2021-08-25
IL225000A (en) 2016-03-31
HRP20211762T1 (hr) 2022-02-18
HK1247841A1 (en) 2018-10-05
PT3251678T (pt) 2021-11-22
US9751898B2 (en) 2017-09-05
PL3251678T3 (pl) 2022-01-10
LT3251678T (lt) 2021-12-10
US8703742B2 (en) 2014-04-22
WO2012033858A3 (en) 2012-05-10
JP2018058836A (ja) 2018-04-12
HUE059033T2 (hu) 2022-10-28
IL244556A0 (en) 2016-04-21
KR102152901B1 (ko) 2020-09-07
EP3251678B1 (en) 2021-10-20
MX2013002651A (es) 2013-04-19
EA028743B1 (ru) 2017-12-29
CA2810021C (en) 2018-05-29
EA201791850A1 (ru) 2018-01-31

Similar Documents

Publication Publication Date Title
CY1124728T1 (el) Παραγωγα βενζοξαβορολης για τη θεραπεια βακτηριακων λοιμωξεων
CY1125220T1 (el) Αμιδο-υποκατεστημενες ετεροκυκλικες ενωσεις χρησιμες ως διαμορφωτες των αποκρισεων il-12, il- 23 και/ή ifn αλφα
CY1124357T1 (el) Προσδιορισμος ανισορροπιας αλληλουχιας νουκλεϊκων οξεων
CY1124537T1 (el) Παραγωγο πυριδονης που εχει τετραϋδροπυρανυλ μεθυλ ομαδα
CY1122065T1 (el) Ενωσεις αλκυλ-αμιδο-υποκατεστημενου πυριδυλιου χρησιμες ως διαμορφωτες των αποκρισεων il-12, il-23 και/η ιfναλφα
CY1121051T1 (el) Περιεχουσα αζωτο ετεροκυκλικη ενωση και γεωργικο/κηπουρικο σποριοκτονο
EA201170096A1 (ru) Замещенные производные пиримидона
EA201390877A1 (ru) Замещенные 6,6-конденсированные азотсодержащие гетероциклические соединения и их применение
CY1120269T1 (el) Ετεροδικυκλικες ενωσεις ως αναστολεις βητα-λακταμασης
CY1117905T1 (el) Αναστολεις πρωτεϊνικης κινασης
CY1119534T1 (el) Παραγωγα φωσφορου ως αναστολεις κινασης
CY1120995T1 (el) Ετεροκυκλικη ενωση και χρηση αυτης
CY1121599T1 (el) Νεο παραγωγο αμινης ή αλας αυτου ως παρεμποδιστες tnf αλφα
CY1122201T1 (el) Παραγωγα βενζοδιοξολιου ως αναστολεις φωσφοδιεστερασης
EA201992884A2 (ru) Арильные, гетероарильные и гетероциклические соединения для лечения заболеваний
CY1117287T1 (el) Πυρρολιδινονη ως αναστολεις metap-2
CY1118102T1 (el) Αλατα διαμινιου φαινοθειαζινης και η χρηση αυτων
AR098912A1 (es) Inhibidores de syk
EA201270077A1 (ru) Соединения и способы лечения гриппа
AR095347A1 (es) Compuestos orgánicos
CY1120477T1 (el) Ενεργοποιητης του υποδοχεα που ενεργοποιειται απο πολλαπλασιαστες των υπεροξεισωματων
CY1110392T1 (el) Υποκατεστημενα παραγωγα μορφολινης και θειομορφολινης
CY1114418T1 (el) Αλατα προσθηκης αμινων που περιεχουν υδροξυλικες ή/και καρβοξυλικες ομαδες με παραγωγα αμινονικοτινικου οξεως ως αναστολεις της dhodh
EA201070871A1 (ru) Бициклические производные азабициклических карбоксамидов, их получение и их применение в терапии
EA201101334A1 (ru) Новые соединения бензотиадиазепина, способ их приготовления и фармацевтические композиции, содержащие их